https://nova.newcastle.edu.au/vital/access/ /manager/Index en-au 5 Interactions with the macrophages: an emerging targeted approach using novel drug delivery systems in respiratory diseases https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:37230 Wed 19 Jan 2022 15:15:18 AEDT ]]> Targeting eosinophils in respiratory diseases: biological axis, emerging therapeutics and treatment modalities https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:46370 Wed 16 Nov 2022 08:45:58 AEDT ]]> Perfluorocarbons therapeutics in modern cancer nanotechnology for hypoxia-induced anti-tumor therapy https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53709 Wed 10 Jan 2024 11:02:51 AEDT ]]> The potential of siRNA based drug delivery in respiratory disorders: recent advances and progress https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:44965 Tue 25 Oct 2022 13:46:05 AEDT ]]> Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): a hypothesis https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49602 Tue 23 May 2023 15:26:55 AEST ]]> Hypoxia-inducible factor (HIF): Fuel for cancer progression https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:53287 Tue 21 Nov 2023 10:23:37 AEDT ]]> Oxidative stress in neurology and in neurodegenerative processes https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:41998 Tue 16 Aug 2022 16:37:32 AEST ]]> Potential anti-epileptic phytoconstituents: An updated review https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:49542 Mon 22 May 2023 08:44:56 AEST ]]> Recent developments in alpha-glucosidase inhibitors for management of type-2 diabetes: An update https://nova.newcastle.edu.au/vital/access/ /manager/Repository/uon:56031 Fri 19 Jul 2024 10:03:20 AEST ]]>